Donna Bratton
Concepts (389)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Granulomatous Disease, Chronic | 8 | 2022 | 61 | 2.970 |
Why?
| Neutrophils | 15 | 2022 | 1233 | 2.010 |
Why?
| Apoptosis | 26 | 2022 | 2484 | 1.820 |
Why?
| Macrophages | 19 | 2022 | 1324 | 1.810 |
Why?
| Phagocytosis | 14 | 2018 | 364 | 1.780 |
Why?
| Lysophospholipids | 5 | 2013 | 68 | 1.540 |
Why?
| Receptors, G-Protein-Coupled | 4 | 2016 | 200 | 1.390 |
Why?
| Oxidants | 6 | 2014 | 122 | 1.330 |
Why?
| Thiazolidinediones | 3 | 2015 | 146 | 1.310 |
Why?
| Cell Cycle Proteins | 5 | 2016 | 565 | 1.210 |
Why?
| NADPH Oxidases | 9 | 2022 | 138 | 1.090 |
Why?
| Phagocytes | 5 | 2017 | 91 | 1.030 |
Why?
| Phosphatidylserines | 7 | 2013 | 91 | 0.920 |
Why?
| Macrophages, Peritoneal | 4 | 2013 | 96 | 0.890 |
Why?
| Mitochondria | 4 | 2015 | 786 | 0.850 |
Why?
| Inflammation | 12 | 2022 | 2566 | 0.780 |
Why?
| Interferon-gamma | 2 | 2016 | 736 | 0.730 |
Why?
| Signal Transduction | 15 | 2022 | 4709 | 0.700 |
Why?
| Inflammation Mediators | 6 | 2017 | 502 | 0.640 |
Why?
| Cytophagocytosis | 2 | 2022 | 10 | 0.620 |
Why?
| PPAR gamma | 3 | 2015 | 188 | 0.580 |
Why?
| Membrane Glycoproteins | 5 | 2014 | 446 | 0.550 |
Why?
| Mice | 29 | 2022 | 15520 | 0.550 |
Why?
| rac1 GTP-Binding Protein | 2 | 2013 | 58 | 0.540 |
Why?
| Animals | 38 | 2022 | 33381 | 0.510 |
Why?
| Mice, Inbred C57BL | 16 | 2022 | 4908 | 0.480 |
Why?
| Neutrophil Activation | 3 | 2013 | 100 | 0.480 |
Why?
| Colitis | 1 | 2016 | 219 | 0.470 |
Why?
| Nitric Oxide | 3 | 2010 | 892 | 0.470 |
Why?
| Peritonitis | 2 | 2013 | 79 | 0.470 |
Why?
| Macrophages, Alveolar | 7 | 2017 | 359 | 0.460 |
Why?
| Leukocyte Disorders | 1 | 2013 | 10 | 0.450 |
Why?
| Mice, Knockout | 10 | 2022 | 2680 | 0.430 |
Why?
| Eosinophils | 3 | 2004 | 282 | 0.420 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2003 | 143 | 0.420 |
Why?
| Receptors, Cell Surface | 3 | 2013 | 367 | 0.420 |
Why?
| Lung | 7 | 2017 | 3664 | 0.410 |
Why?
| NADPH Oxidase 2 | 5 | 2014 | 42 | 0.410 |
Why?
| Lipids | 2 | 2013 | 607 | 0.380 |
Why?
| Respiratory Mucosa | 1 | 2013 | 254 | 0.380 |
Why?
| Hypersensitivity | 1 | 2013 | 268 | 0.350 |
Why?
| Cells, Cultured | 10 | 2015 | 4077 | 0.340 |
Why?
| Asthma | 6 | 2012 | 2158 | 0.340 |
Why?
| Reperfusion Injury | 1 | 2011 | 276 | 0.330 |
Why?
| Fundoplication | 1 | 2008 | 56 | 0.310 |
Why?
| Hypoglycemic Agents | 1 | 2015 | 1032 | 0.310 |
Why?
| Interleukin-4 | 1 | 2008 | 215 | 0.310 |
Why?
| Secretory Vesicles | 1 | 2007 | 24 | 0.300 |
Why?
| Membrane Microdomains | 2 | 2004 | 35 | 0.300 |
Why?
| Immunotherapy | 1 | 2011 | 493 | 0.300 |
Why?
| Acetates | 2 | 2004 | 98 | 0.300 |
Why?
| Epithelial Cells | 1 | 2013 | 963 | 0.290 |
Why?
| Pulmonary Disease, Chronic Obstructive | 3 | 2013 | 1137 | 0.290 |
Why?
| Quinolines | 2 | 2004 | 128 | 0.290 |
Why?
| Disease Models, Animal | 6 | 2016 | 3730 | 0.290 |
Why?
| Reactive Oxygen Species | 5 | 2018 | 576 | 0.280 |
Why?
| Transforming Growth Factor beta | 4 | 2013 | 462 | 0.280 |
Why?
| Flow Cytometry | 3 | 2016 | 1085 | 0.260 |
Why?
| Calcium Signaling | 1 | 2007 | 219 | 0.260 |
Why?
| Gastroesophageal Reflux | 1 | 2008 | 248 | 0.260 |
Why?
| Blotting, Western | 6 | 2013 | 1194 | 0.260 |
Why?
| Phospholipid Transfer Proteins | 1 | 2004 | 11 | 0.240 |
Why?
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2004 | 67 | 0.240 |
Why?
| Acute Lung Injury | 2 | 2017 | 310 | 0.240 |
Why?
| Laparoscopy | 1 | 2008 | 417 | 0.230 |
Why?
| Anti-Asthmatic Agents | 2 | 2004 | 343 | 0.230 |
Why?
| Respiration | 1 | 2004 | 183 | 0.230 |
Why?
| Dinoprostone | 3 | 2013 | 193 | 0.230 |
Why?
| Health Resources | 1 | 2004 | 132 | 0.230 |
Why?
| Humans | 42 | 2022 | 118974 | 0.220 |
Why?
| Jurkat Cells | 6 | 2012 | 134 | 0.220 |
Why?
| Dexamethasone | 2 | 2012 | 320 | 0.210 |
Why?
| Male | 20 | 2022 | 57801 | 0.210 |
Why?
| Enzyme Activation | 4 | 2010 | 828 | 0.210 |
Why?
| Monocytes | 3 | 2014 | 513 | 0.210 |
Why?
| Polyamines | 1 | 2022 | 39 | 0.210 |
Why?
| Interleukin-15 | 1 | 2002 | 77 | 0.210 |
Why?
| Mice, Transgenic | 7 | 2022 | 2025 | 0.210 |
Why?
| Cell Differentiation | 2 | 2008 | 1753 | 0.210 |
Why?
| Membrane Proteins | 2 | 2008 | 1055 | 0.200 |
Why?
| Adjuvants, Immunologic | 1 | 2003 | 207 | 0.200 |
Why?
| Superoxides | 4 | 2018 | 221 | 0.200 |
Why?
| Lymph Nodes | 3 | 2016 | 455 | 0.190 |
Why?
| Tumor Necrosis Factor-alpha | 4 | 2014 | 1171 | 0.190 |
Why?
| Eicosanoids | 2 | 2013 | 57 | 0.190 |
Why?
| Cytokines | 5 | 2018 | 1900 | 0.180 |
Why?
| Zymosan | 2 | 2010 | 64 | 0.180 |
Why?
| Dermatitis, Atopic | 2 | 2017 | 332 | 0.180 |
Why?
| Carrier Proteins | 1 | 2004 | 726 | 0.180 |
Why?
| NF-kappa B | 2 | 2006 | 670 | 0.170 |
Why?
| Autoimmunity | 1 | 2005 | 831 | 0.170 |
Why?
| Proto-Oncogene Proteins | 2 | 2017 | 618 | 0.160 |
Why?
| src-Family Kinases | 2 | 2013 | 90 | 0.160 |
Why?
| Cytotoxicity, Immunologic | 1 | 2018 | 204 | 0.150 |
Why?
| c-Mer Tyrosine Kinase | 1 | 2017 | 43 | 0.150 |
Why?
| Female | 17 | 2022 | 61565 | 0.150 |
Why?
| Lung Diseases | 1 | 2004 | 718 | 0.150 |
Why?
| Cell Communication | 2 | 2011 | 281 | 0.150 |
Why?
| Angioedema | 1 | 2017 | 17 | 0.150 |
Why?
| Rhinitis, Allergic, Seasonal | 1 | 2017 | 32 | 0.150 |
Why?
| Gene Expression Regulation | 3 | 2013 | 2445 | 0.150 |
Why?
| Superoxide Dismutase | 3 | 2010 | 339 | 0.150 |
Why?
| Cell-Derived Microparticles | 1 | 2017 | 62 | 0.150 |
Why?
| Proteins | 1 | 2003 | 938 | 0.140 |
Why?
| Mycobacterium abscessus | 1 | 2018 | 97 | 0.140 |
Why?
| Mononuclear Phagocyte System | 1 | 2016 | 14 | 0.140 |
Why?
| Dextran Sulfate | 1 | 2016 | 71 | 0.140 |
Why?
| Group IV Phospholipases A2 | 2 | 2013 | 46 | 0.130 |
Why?
| Face | 1 | 2017 | 165 | 0.130 |
Why?
| Myeloid Cells | 1 | 2016 | 128 | 0.130 |
Why?
| Cell Membrane | 2 | 2013 | 710 | 0.130 |
Why?
| Receptor Protein-Tyrosine Kinases | 1 | 2017 | 229 | 0.130 |
Why?
| CD36 Antigens | 2 | 2013 | 42 | 0.130 |
Why?
| Severity of Illness Index | 3 | 2013 | 2674 | 0.120 |
Why?
| Metalloproteases | 1 | 2014 | 38 | 0.120 |
Why?
| Cromolyn Sodium | 2 | 2004 | 13 | 0.120 |
Why?
| Cyclic AMP | 2 | 2013 | 242 | 0.120 |
Why?
| Quorum Sensing | 1 | 2014 | 72 | 0.120 |
Why?
| Membrane Lipids | 2 | 2005 | 88 | 0.120 |
Why?
| Protein Biosynthesis | 2 | 2008 | 397 | 0.120 |
Why?
| Endothelial Progenitor Cells | 1 | 2013 | 18 | 0.120 |
Why?
| MAP Kinase Signaling System | 2 | 2013 | 292 | 0.120 |
Why?
| Candida albicans | 1 | 2013 | 58 | 0.120 |
Why?
| Lupus Erythematosus, Systemic | 2 | 2016 | 227 | 0.110 |
Why?
| Virulence Factors | 1 | 2014 | 140 | 0.110 |
Why?
| Glycoproteins | 2 | 2013 | 319 | 0.110 |
Why?
| Phospholipids | 2 | 2005 | 208 | 0.110 |
Why?
| Pharmaceutical Preparations | 1 | 2014 | 167 | 0.110 |
Why?
| Mycobacterium Infections | 1 | 2013 | 61 | 0.110 |
Why?
| Transforming Growth Factor beta1 | 1 | 2013 | 164 | 0.110 |
Why?
| Pseudomonas aeruginosa | 1 | 2014 | 305 | 0.100 |
Why?
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2012 | 67 | 0.100 |
Why?
| Mycobacterium | 1 | 2013 | 103 | 0.100 |
Why?
| Ischemia | 1 | 2014 | 374 | 0.100 |
Why?
| Phospholipases A2, Calcium-Independent | 1 | 2011 | 4 | 0.100 |
Why?
| Mycoplasma pneumoniae | 1 | 2011 | 33 | 0.100 |
Why?
| Pneumonia, Mycoplasma | 1 | 2011 | 33 | 0.100 |
Why?
| Prostaglandin-Endoperoxide Synthases | 1 | 2011 | 61 | 0.100 |
Why?
| Staphylococcus aureus | 1 | 2014 | 394 | 0.100 |
Why?
| Adenylyl Cyclases | 1 | 2011 | 86 | 0.100 |
Why?
| Hematopoietic Stem Cells | 1 | 2013 | 359 | 0.090 |
Why?
| Spectrometry, Mass, Electrospray Ionization | 1 | 2011 | 171 | 0.090 |
Why?
| Complement C3 | 1 | 2011 | 192 | 0.090 |
Why?
| Receptors, Immunologic | 2 | 2015 | 209 | 0.090 |
Why?
| Cell Line | 5 | 2012 | 2707 | 0.090 |
Why?
| Pulmonary Emphysema | 1 | 2013 | 327 | 0.090 |
Why?
| Leukocyte Common Antigens | 2 | 2013 | 76 | 0.090 |
Why?
| Transcription, Genetic | 3 | 2017 | 1323 | 0.090 |
Why?
| CD47 Antigen | 2 | 2006 | 22 | 0.090 |
Why?
| Oxidative Stress | 3 | 2012 | 1178 | 0.090 |
Why?
| Calreticulin | 2 | 2006 | 24 | 0.090 |
Why?
| Anti-Inflammatory Agents | 1 | 2013 | 465 | 0.090 |
Why?
| Smoke | 1 | 2010 | 143 | 0.090 |
Why?
| Phosphoproteins | 1 | 2011 | 308 | 0.080 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2012 | 527 | 0.080 |
Why?
| Gene Expression Profiling | 4 | 2017 | 1597 | 0.080 |
Why?
| Gene Deletion | 1 | 2010 | 361 | 0.080 |
Why?
| Tandem Mass Spectrometry | 1 | 2011 | 421 | 0.080 |
Why?
| Administration, Inhalation | 3 | 2004 | 656 | 0.080 |
Why?
| Adolescent | 5 | 2015 | 18480 | 0.080 |
Why?
| Hypoxia | 1 | 2014 | 963 | 0.080 |
Why?
| Idiopathic Pulmonary Fibrosis | 1 | 2014 | 451 | 0.080 |
Why?
| Angiogenic Proteins | 1 | 2008 | 21 | 0.080 |
Why?
| Cell Adhesion Molecules, Neuronal | 1 | 2008 | 35 | 0.080 |
Why?
| Allergens | 2 | 2017 | 424 | 0.080 |
Why?
| Cyclopropanes | 2 | 2004 | 80 | 0.080 |
Why?
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2007 | 14 | 0.080 |
Why?
| Immunoglobulin G | 1 | 2011 | 788 | 0.070 |
Why?
| Type C Phospholipases | 1 | 2007 | 66 | 0.070 |
Why?
| Recombinant Proteins | 1 | 2010 | 1308 | 0.070 |
Why?
| Phospholipases A | 1 | 2007 | 101 | 0.070 |
Why?
| Sulfides | 2 | 2004 | 96 | 0.070 |
Why?
| Cell Death | 1 | 2008 | 339 | 0.070 |
Why?
| Child | 6 | 2017 | 19129 | 0.070 |
Why?
| Fibroblasts | 2 | 2008 | 842 | 0.070 |
Why?
| Respiratory Function Tests | 1 | 2008 | 526 | 0.070 |
Why?
| Reproducibility of Results | 3 | 2017 | 2874 | 0.070 |
Why?
| Antibodies | 1 | 2008 | 392 | 0.070 |
Why?
| Antigens, Surface | 1 | 2006 | 156 | 0.070 |
Why?
| Oxidation-Reduction | 1 | 2008 | 940 | 0.070 |
Why?
| Immunity, Innate | 1 | 2011 | 745 | 0.070 |
Why?
| Administration, Oral | 2 | 2004 | 756 | 0.060 |
Why?
| Mitogen-Activated Protein Kinases | 2 | 2004 | 298 | 0.060 |
Why?
| cdc42 GTP-Binding Protein | 1 | 2004 | 25 | 0.060 |
Why?
| Cell Lineage | 2 | 2017 | 318 | 0.060 |
Why?
| beta-Cyclodextrins | 1 | 2004 | 31 | 0.060 |
Why?
| Factor Va | 1 | 2004 | 3 | 0.060 |
Why?
| Chemotaxis, Leukocyte | 1 | 2004 | 133 | 0.060 |
Why?
| Pinocytosis | 1 | 2004 | 11 | 0.060 |
Why?
| Annexin A5 | 1 | 2004 | 24 | 0.060 |
Why?
| Cholera Toxin | 1 | 2004 | 28 | 0.060 |
Why?
| Adult | 6 | 2016 | 31512 | 0.060 |
Why?
| Phosphorylcholine | 1 | 2004 | 18 | 0.060 |
Why?
| Phosphoserine | 1 | 2004 | 34 | 0.060 |
Why?
| Breath Tests | 1 | 2004 | 89 | 0.060 |
Why?
| Detergents | 1 | 2004 | 44 | 0.060 |
Why?
| Isoquinolines | 1 | 2004 | 41 | 0.060 |
Why?
| Subcellular Fractions | 1 | 2004 | 84 | 0.060 |
Why?
| Child, Preschool | 4 | 2008 | 9491 | 0.060 |
Why?
| Autoantibodies | 1 | 2011 | 1335 | 0.060 |
Why?
| Transcriptional Activation | 1 | 2005 | 348 | 0.060 |
Why?
| Alkaline Phosphatase | 1 | 2004 | 157 | 0.060 |
Why?
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2003 | 13 | 0.060 |
Why?
| Dose-Response Relationship, Immunologic | 1 | 2003 | 82 | 0.060 |
Why?
| Antioxidants | 2 | 2007 | 564 | 0.060 |
Why?
| Endocytosis | 1 | 2004 | 156 | 0.060 |
Why?
| Phosphatidylinositol 3-Kinases | 2 | 2022 | 341 | 0.060 |
Why?
| Intracellular Membranes | 1 | 2003 | 74 | 0.060 |
Why?
| Cloning, Molecular | 1 | 2004 | 546 | 0.060 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2004 | 226 | 0.050 |
Why?
| Reference Values | 1 | 2004 | 774 | 0.050 |
Why?
| Permeability | 1 | 2003 | 156 | 0.050 |
Why?
| JNK Mitogen-Activated Protein Kinases | 1 | 2003 | 155 | 0.050 |
Why?
| Spermidine | 1 | 2022 | 12 | 0.050 |
Why?
| Membrane Potentials | 1 | 2003 | 253 | 0.050 |
Why?
| Family Relations | 1 | 2002 | 85 | 0.050 |
Why?
| Middle Aged | 5 | 2015 | 27617 | 0.050 |
Why?
| Spermine | 1 | 2022 | 28 | 0.050 |
Why?
| Leukocyte Elastase | 1 | 2002 | 80 | 0.050 |
Why?
| Sputum | 2 | 2014 | 290 | 0.050 |
Why?
| Transfection | 1 | 2004 | 888 | 0.050 |
Why?
| Phosphoric Monoester Hydrolases | 1 | 2001 | 57 | 0.050 |
Why?
| Biofilms | 2 | 2014 | 231 | 0.050 |
Why?
| Protein Structure, Tertiary | 1 | 2004 | 823 | 0.050 |
Why?
| Immunomodulation | 1 | 2022 | 89 | 0.050 |
Why?
| Patients | 1 | 2002 | 175 | 0.050 |
Why?
| Healthy Volunteers | 1 | 2022 | 201 | 0.050 |
Why?
| Protein Binding | 2 | 2004 | 1975 | 0.050 |
Why?
| Adrenal Cortex Hormones | 1 | 2004 | 521 | 0.050 |
Why?
| Bronchiectasis | 1 | 2002 | 105 | 0.050 |
Why?
| Double-Blind Method | 1 | 2004 | 1687 | 0.050 |
Why?
| Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 827 | 0.050 |
Why?
| Young Adult | 1 | 2015 | 10793 | 0.050 |
Why?
| Dual Specificity Phosphatase 1 | 2 | 2012 | 29 | 0.050 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 982 | 0.050 |
Why?
| Cyclooxygenase 2 | 2 | 2013 | 168 | 0.040 |
Why?
| Obesity | 1 | 2012 | 2746 | 0.040 |
Why?
| Cystic Fibrosis | 2 | 2014 | 964 | 0.040 |
Why?
| Time Factors | 2 | 2014 | 6412 | 0.040 |
Why?
| Patient Satisfaction | 1 | 2003 | 610 | 0.040 |
Why?
| Gene Expression | 2 | 2014 | 1489 | 0.040 |
Why?
| Cell Proliferation | 2 | 2017 | 2275 | 0.040 |
Why?
| Intracellular Space | 1 | 2018 | 69 | 0.040 |
Why?
| Extracellular Traps | 1 | 2018 | 40 | 0.040 |
Why?
| Microbial Viability | 1 | 2018 | 81 | 0.040 |
Why?
| Extracellular Space | 1 | 2018 | 127 | 0.040 |
Why?
| Mice, Inbred BALB C | 2 | 2013 | 1206 | 0.040 |
Why?
| Histamine Antagonists | 1 | 2017 | 19 | 0.040 |
Why?
| Pollen | 1 | 2017 | 27 | 0.040 |
Why?
| Antigens, CD | 2 | 2013 | 460 | 0.040 |
Why?
| Pruritus | 1 | 2017 | 60 | 0.040 |
Why?
| Trees | 1 | 2017 | 67 | 0.040 |
Why?
| Antigens, Plant | 1 | 2017 | 53 | 0.040 |
Why?
| DNA | 1 | 2004 | 1388 | 0.040 |
Why?
| Age Factors | 1 | 2004 | 2995 | 0.040 |
Why?
| Arachidonic Acid | 2 | 2007 | 122 | 0.040 |
Why?
| Organ Specificity | 1 | 2017 | 278 | 0.040 |
Why?
| Lymphohistiocytosis, Hemophagocytic | 1 | 2016 | 28 | 0.040 |
Why?
| Steroids | 1 | 2017 | 153 | 0.040 |
Why?
| Bone Marrow Cells | 1 | 2017 | 273 | 0.040 |
Why?
| Caregivers | 1 | 2002 | 709 | 0.030 |
Why?
| rho GTP-Binding Proteins | 2 | 2007 | 65 | 0.030 |
Why?
| Transplantation Chimera | 1 | 2015 | 51 | 0.030 |
Why?
| Prolyl Hydroxylases | 1 | 2014 | 4 | 0.030 |
Why?
| Sequence Analysis, RNA | 1 | 2017 | 409 | 0.030 |
Why?
| Up-Regulation | 2 | 2010 | 872 | 0.030 |
Why?
| Cadaver | 1 | 2016 | 327 | 0.030 |
Why?
| Cellular Microenvironment | 1 | 2015 | 79 | 0.030 |
Why?
| Tobramycin | 1 | 2014 | 50 | 0.030 |
Why?
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2014 | 7 | 0.030 |
Why?
| Hydroxyproline | 1 | 2014 | 24 | 0.030 |
Why?
| Tacrolimus Binding Proteins | 1 | 2014 | 17 | 0.030 |
Why?
| Drug Resistance, Multiple, Bacterial | 1 | 2014 | 63 | 0.030 |
Why?
| Lung Compliance | 1 | 2014 | 49 | 0.030 |
Why?
| Bone Marrow Transplantation | 1 | 2015 | 244 | 0.030 |
Why?
| AC133 Antigen | 1 | 2013 | 20 | 0.030 |
Why?
| Dendritic Cells | 1 | 2017 | 442 | 0.030 |
Why?
| Treatment Outcome | 1 | 2008 | 9342 | 0.030 |
Why?
| Azithromycin | 1 | 2014 | 81 | 0.030 |
Why?
| Colony-Forming Units Assay | 1 | 2013 | 93 | 0.030 |
Why?
| Leukotriene C4 | 1 | 2013 | 13 | 0.030 |
Why?
| fas Receptor | 1 | 2014 | 98 | 0.030 |
Why?
| Antigens, CD34 | 1 | 2013 | 98 | 0.030 |
Why?
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2013 | 86 | 0.030 |
Why?
| Remission Induction | 1 | 2014 | 247 | 0.030 |
Why?
| Microbial Sensitivity Tests | 1 | 2014 | 302 | 0.030 |
Why?
| Receptors, Transforming Growth Factor beta | 1 | 2013 | 53 | 0.030 |
Why?
| Autoimmune Diseases | 1 | 2016 | 398 | 0.030 |
Why?
| PPAR delta | 1 | 2012 | 6 | 0.030 |
Why?
| Mycobacterium Infections, Nontuberculous | 1 | 2018 | 334 | 0.030 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 770 | 0.030 |
Why?
| Cell Count | 1 | 2013 | 315 | 0.030 |
Why?
| Vital Capacity | 1 | 2013 | 260 | 0.030 |
Why?
| Receptors, Chemokine | 1 | 2012 | 45 | 0.030 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 219 | 0.030 |
Why?
| Models, Biological | 3 | 2006 | 1715 | 0.030 |
Why?
| Pseudomonas Infections | 1 | 2014 | 193 | 0.030 |
Why?
| Parents | 3 | 2008 | 1212 | 0.030 |
Why?
| Epoprostenol | 1 | 2013 | 132 | 0.030 |
Why?
| Bleomycin | 1 | 2014 | 228 | 0.030 |
Why?
| Pulmonary Alveoli | 1 | 2015 | 384 | 0.030 |
Why?
| Metabolomics | 1 | 2017 | 550 | 0.030 |
Why?
| Antibodies, Monoclonal | 2 | 2012 | 1284 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 333 | 0.030 |
Why?
| Cell Movement | 1 | 2016 | 896 | 0.030 |
Why?
| Forced Expiratory Volume | 1 | 2013 | 520 | 0.030 |
Why?
| In Vitro Techniques | 2 | 2006 | 1094 | 0.030 |
Why?
| Doxycycline | 1 | 2012 | 60 | 0.030 |
Why?
| Aldehydes | 1 | 2012 | 154 | 0.030 |
Why?
| Quality of Life | 1 | 2002 | 2366 | 0.030 |
Why?
| Pneumonia | 1 | 2017 | 592 | 0.030 |
Why?
| Receptors, Glucocorticoid | 1 | 2012 | 133 | 0.030 |
Why?
| Immunity, Cellular | 1 | 2013 | 270 | 0.030 |
Why?
| Lipopolysaccharides | 2 | 2006 | 870 | 0.030 |
Why?
| Chemokine CXCL2 | 1 | 2010 | 44 | 0.020 |
Why?
| Onium Compounds | 1 | 2010 | 13 | 0.020 |
Why?
| Pyrroles | 1 | 2012 | 191 | 0.020 |
Why?
| Emphysema | 1 | 2012 | 123 | 0.020 |
Why?
| Recovery of Function | 1 | 2014 | 604 | 0.020 |
Why?
| Indoles | 1 | 2012 | 316 | 0.020 |
Why?
| Phenotype | 1 | 2017 | 3003 | 0.020 |
Why?
| 3T3 Cells | 1 | 2008 | 141 | 0.020 |
Why?
| Autoantigens | 1 | 2011 | 397 | 0.020 |
Why?
| Phosphorylation | 2 | 2004 | 1633 | 0.020 |
Why?
| Glucocorticoids | 1 | 2012 | 545 | 0.020 |
Why?
| Peptides | 1 | 2013 | 879 | 0.020 |
Why?
| Statistics, Nonparametric | 1 | 2008 | 403 | 0.020 |
Why?
| Phospholipases A2 | 1 | 2007 | 77 | 0.020 |
Why?
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2007 | 36 | 0.020 |
Why?
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2007 | 79 | 0.020 |
Why?
| Metalloporphyrins | 1 | 2007 | 103 | 0.020 |
Why?
| Enzyme Inhibitors | 1 | 2010 | 827 | 0.020 |
Why?
| Collectins | 1 | 2006 | 12 | 0.020 |
Why?
| Leukemia, Plasma Cell | 1 | 2006 | 5 | 0.020 |
Why?
| Protein Phosphatase 1 | 1 | 2006 | 32 | 0.020 |
Why?
| Smad2 Protein | 1 | 2006 | 39 | 0.020 |
Why?
| Microscopy, Video | 1 | 2005 | 27 | 0.020 |
Why?
| Phosphoprotein Phosphatases | 1 | 2006 | 67 | 0.020 |
Why?
| Immediate-Early Proteins | 1 | 2006 | 55 | 0.020 |
Why?
| RNA, Messenger | 1 | 2013 | 2657 | 0.020 |
Why?
| Hydrogen Peroxide | 1 | 2007 | 305 | 0.020 |
Why?
| Nitric Oxide Synthase Type II | 1 | 2006 | 165 | 0.020 |
Why?
| Genes, Reporter | 1 | 2006 | 270 | 0.020 |
Why?
| Protein Tyrosine Phosphatases | 1 | 2006 | 145 | 0.020 |
Why?
| Anti-Bacterial Agents | 1 | 2014 | 1510 | 0.020 |
Why?
| Embryo, Mammalian | 1 | 2005 | 220 | 0.020 |
Why?
| Heterozygote | 1 | 2005 | 262 | 0.020 |
Why?
| Bronchial Provocation Tests | 1 | 2004 | 54 | 0.020 |
Why?
| Cyclodextrins | 1 | 2004 | 15 | 0.020 |
Why?
| Thorax | 1 | 2004 | 45 | 0.020 |
Why?
| rac GTP-Binding Proteins | 1 | 2004 | 36 | 0.020 |
Why?
| Genes, MHC Class II | 1 | 2004 | 72 | 0.020 |
Why?
| Ligands | 1 | 2006 | 567 | 0.020 |
Why?
| bcl-2-Associated X Protein | 1 | 2004 | 46 | 0.020 |
Why?
| Antigen Presentation | 1 | 2004 | 194 | 0.010 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 285 | 0.010 |
Why?
| Cytoplasm | 1 | 2004 | 269 | 0.010 |
Why?
| Phosphates | 1 | 2004 | 167 | 0.010 |
Why?
| Cholesterol | 1 | 2004 | 373 | 0.010 |
Why?
| Infant | 2 | 2008 | 8293 | 0.010 |
Why?
| Albuterol | 1 | 2003 | 104 | 0.010 |
Why?
| Cohort Studies | 1 | 2012 | 5116 | 0.010 |
Why?
| Protein Transport | 1 | 2004 | 412 | 0.010 |
Why?
| Biomarkers | 1 | 2012 | 3588 | 0.010 |
Why?
| Inositol Phosphates | 1 | 2001 | 23 | 0.010 |
Why?
| Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases | 1 | 2001 | 13 | 0.010 |
Why?
| Actins | 1 | 2004 | 404 | 0.010 |
Why?
| Precipitin Tests | 1 | 2001 | 93 | 0.010 |
Why?
| Foster Home Care | 1 | 2002 | 65 | 0.010 |
Why?
| Cell Division | 1 | 2004 | 776 | 0.010 |
Why?
| Receptors, IgG | 1 | 2002 | 67 | 0.010 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2004 | 420 | 0.010 |
Why?
| Jumonji Domain-Containing Histone Demethylases | 1 | 2002 | 59 | 0.010 |
Why?
| Cross-Over Studies | 1 | 2003 | 456 | 0.010 |
Why?
| Bronchodilator Agents | 1 | 2003 | 253 | 0.010 |
Why?
| Aged | 2 | 2013 | 19657 | 0.010 |
Why?
| Parent-Child Relations | 1 | 2002 | 232 | 0.010 |
Why?
| Acute Disease | 1 | 2002 | 940 | 0.010 |
Why?
| Stress, Physiological | 1 | 2002 | 415 | 0.010 |
Why?
| Patient Compliance | 1 | 2003 | 537 | 0.010 |
Why?
| Lipid Metabolism | 1 | 2001 | 477 | 0.010 |
Why?
| Oxygen | 1 | 2001 | 854 | 0.010 |
Why?
| Patient Discharge | 1 | 2002 | 796 | 0.010 |
Why?
| Anxiety | 1 | 2002 | 845 | 0.010 |
Why?
| Incidence | 1 | 2002 | 2424 | 0.010 |
Why?
| Depression | 1 | 2002 | 1132 | 0.010 |
Why?
| Hospitalization | 1 | 2002 | 1785 | 0.010 |
Why?
| Emergency Service, Hospital | 1 | 2002 | 1865 | 0.010 |
Why?
| Surveys and Questionnaires | 1 | 2002 | 4708 | 0.010 |
Why?
|
|
Bratton's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|